Free Trial

Bain Capital Specialty Finance (BCSF) Competitors

Bain Capital Specialty Finance logo
$10.26 -0.37 (-3.43%)
Closing price 10/16/2026 03:59 PM Eastern
Extended Trading
$10.28 +0.01 (+0.15%)
As of 10/16/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BCSF vs. ARCC, CCAP, CGBD, MFIC, and NMFC

Should you buy Bain Capital Specialty Finance stock or one of its competitors? Bain Capital Specialty Finance's main competitors and comparable companies include Ares Capital (ARCC), Crescent Capital BDC (CCAP), Carlyle Secured Lending (CGBD), MidCap Financial Investment (MFIC), and New Mountain Finance (NMFC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "asset management & custody banks" industry.

How does Bain Capital Specialty Finance compare to Ares Capital?

Bain Capital Specialty Finance (NYSE:BCSF) and Ares Capital (NASDAQ:ARCC) are both finance companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, dividends, risk, earnings, valuation and media sentiment.

Ares Capital has a net margin of 30.91% compared to Bain Capital Specialty Finance's net margin of 24.22%. Bain Capital Specialty Finance's return on equity of 10.40% beat Ares Capital's return on equity.

Company Net Margins Return on Equity Return on Assets
Bain Capital Specialty Finance24.22% 10.40% 4.33%
Ares Capital 30.91%9.80%4.50%

Bain Capital Specialty Finance currently has a consensus target price of $12.60, indicating a potential upside of 22.75%. Ares Capital has a consensus target price of $20.39, indicating a potential upside of 8.92%. Given Bain Capital Specialty Finance's higher probable upside, research analysts clearly believe Bain Capital Specialty Finance is more favorable than Ares Capital.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bain Capital Specialty Finance
0 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Ares Capital
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73

In the previous week, Ares Capital had 6 more articles in the media than Bain Capital Specialty Finance. MarketBeat recorded 14 mentions for Ares Capital and 8 mentions for Bain Capital Specialty Finance. Bain Capital Specialty Finance's average media sentiment score of 0.75 beat Ares Capital's score of 0.52 indicating that Bain Capital Specialty Finance is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bain Capital Specialty Finance
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Ares Capital
6 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
3 Negative mention(s)
1 Very Negative mention(s)
Positive

Bain Capital Specialty Finance has a beta of 0.6, meaning that its stock price is 40% less volatile than the broader market. Comparatively, Ares Capital has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market.

27.4% of Ares Capital shares are owned by institutional investors. 0.6% of Bain Capital Specialty Finance shares are owned by insiders. Comparatively, 0.5% of Ares Capital shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Ares Capital has higher revenue and earnings than Bain Capital Specialty Finance. Bain Capital Specialty Finance is trading at a lower price-to-earnings ratio than Ares Capital, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bain Capital Specialty Finance$78.39M8.49$98.76M$0.9910.37
Ares Capital$3.05B4.40$1.30B$1.3513.87

Bain Capital Specialty Finance pays an annual dividend of $1.68 per share and has a dividend yield of 16.4%. Ares Capital pays an annual dividend of $1.92 per share and has a dividend yield of 10.3%. Bain Capital Specialty Finance pays out 169.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Ares Capital pays out 142.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Bain Capital Specialty Finance has raised its dividend for 4 consecutive years. Bain Capital Specialty Finance is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Ares Capital beats Bain Capital Specialty Finance on 12 of the 19 factors compared between the two stocks.

How does Bain Capital Specialty Finance compare to Crescent Capital BDC?

Bain Capital Specialty Finance (NYSE:BCSF) and Crescent Capital BDC (NASDAQ:CCAP) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, media sentiment, institutional ownership, risk, earnings and dividends.

Bain Capital Specialty Finance pays an annual dividend of $1.68 per share and has a dividend yield of 16.4%. Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 15.3%. Bain Capital Specialty Finance pays out 169.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC pays out -1,511.1% of its earnings in the form of a dividend. Bain Capital Specialty Finance has raised its dividend for 4 consecutive years and Crescent Capital BDC has raised its dividend for 1 consecutive years. Bain Capital Specialty Finance is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Bain Capital Specialty Finance presently has a consensus target price of $12.60, suggesting a potential upside of 22.75%. Crescent Capital BDC has a consensus target price of $12.63, suggesting a potential upside of 41.85%. Given Crescent Capital BDC's stronger consensus rating and higher possible upside, analysts plainly believe Crescent Capital BDC is more favorable than Bain Capital Specialty Finance.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bain Capital Specialty Finance
0 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Crescent Capital BDC
0 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.14

49.5% of Crescent Capital BDC shares are owned by institutional investors. 0.6% of Bain Capital Specialty Finance shares are owned by insiders. Comparatively, 1.2% of Crescent Capital BDC shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Bain Capital Specialty Finance has a beta of 0.6, meaning that its share price is 40% less volatile than the broader market. Comparatively, Crescent Capital BDC has a beta of 0.57, meaning that its share price is 43% less volatile than the broader market.

In the previous week, Bain Capital Specialty Finance had 8 more articles in the media than Crescent Capital BDC. MarketBeat recorded 8 mentions for Bain Capital Specialty Finance and 0 mentions for Crescent Capital BDC. Bain Capital Specialty Finance's average media sentiment score of 0.75 beat Crescent Capital BDC's score of 0.00 indicating that Bain Capital Specialty Finance is being referred to more favorably in the media.

Company Overall Sentiment
Bain Capital Specialty Finance Positive
Crescent Capital BDC Neutral

Bain Capital Specialty Finance has a net margin of 24.22% compared to Crescent Capital BDC's net margin of -2.02%. Bain Capital Specialty Finance's return on equity of 10.40% beat Crescent Capital BDC's return on equity.

Company Net Margins Return on Equity Return on Assets
Bain Capital Specialty Finance24.22% 10.40% 4.33%
Crescent Capital BDC -2.02%9.02%3.82%

Bain Capital Specialty Finance has higher earnings, but lower revenue than Crescent Capital BDC. Crescent Capital BDC is trading at a lower price-to-earnings ratio than Bain Capital Specialty Finance, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bain Capital Specialty Finance$78.39M8.49$98.76M$0.9910.37
Crescent Capital BDC$167.29M1.96$34.51M-$0.09N/A

Summary

Bain Capital Specialty Finance beats Crescent Capital BDC on 12 of the 19 factors compared between the two stocks.

How does Bain Capital Specialty Finance compare to Carlyle Secured Lending?

Bain Capital Specialty Finance (NYSE:BCSF) and Carlyle Secured Lending (NASDAQ:CGBD) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

In the previous week, Bain Capital Specialty Finance had 3 more articles in the media than Carlyle Secured Lending. MarketBeat recorded 8 mentions for Bain Capital Specialty Finance and 5 mentions for Carlyle Secured Lending. Carlyle Secured Lending's average media sentiment score of 0.88 beat Bain Capital Specialty Finance's score of 0.75 indicating that Carlyle Secured Lending is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bain Capital Specialty Finance
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Carlyle Secured Lending
1 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Bain Capital Specialty Finance pays an annual dividend of $1.68 per share and has a dividend yield of 16.4%. Carlyle Secured Lending pays an annual dividend of $1.40 per share and has a dividend yield of 13.5%. Bain Capital Specialty Finance pays out 169.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Carlyle Secured Lending pays out 274.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Bain Capital Specialty Finance has increased its dividend for 4 consecutive years. Bain Capital Specialty Finance is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Bain Capital Specialty Finance has a net margin of 24.22% compared to Carlyle Secured Lending's net margin of 14.26%. Bain Capital Specialty Finance's return on equity of 10.40% beat Carlyle Secured Lending's return on equity.

Company Net Margins Return on Equity Return on Assets
Bain Capital Specialty Finance24.22% 10.40% 4.33%
Carlyle Secured Lending 14.26%8.85%3.90%

Bain Capital Specialty Finance currently has a consensus price target of $12.60, suggesting a potential upside of 22.75%. Carlyle Secured Lending has a consensus price target of $11.33, suggesting a potential upside of 9.08%. Given Bain Capital Specialty Finance's higher possible upside, equities research analysts plainly believe Bain Capital Specialty Finance is more favorable than Carlyle Secured Lending.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bain Capital Specialty Finance
0 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Carlyle Secured Lending
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50

24.5% of Carlyle Secured Lending shares are owned by institutional investors. 0.6% of Bain Capital Specialty Finance shares are owned by company insiders. Comparatively, 0.4% of Carlyle Secured Lending shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Bain Capital Specialty Finance has higher revenue and earnings than Carlyle Secured Lending. Bain Capital Specialty Finance is trading at a lower price-to-earnings ratio than Carlyle Secured Lending, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bain Capital Specialty Finance$78.39M8.49$98.76M$0.9910.37
Carlyle Secured Lending$48.71M14.68$69.97M$0.5120.37

Bain Capital Specialty Finance has a beta of 0.6, meaning that its stock price is 40% less volatile than the broader market. Comparatively, Carlyle Secured Lending has a beta of 0.66, meaning that its stock price is 34% less volatile than the broader market.

Summary

Bain Capital Specialty Finance beats Carlyle Secured Lending on 12 of the 20 factors compared between the two stocks.

How does Bain Capital Specialty Finance compare to MidCap Financial Investment?

MidCap Financial Investment (NASDAQ:MFIC) and Bain Capital Specialty Finance (NYSE:BCSF) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation, institutional ownership and media sentiment.

Bain Capital Specialty Finance has lower revenue, but higher earnings than MidCap Financial Investment. MidCap Financial Investment is trading at a lower price-to-earnings ratio than Bain Capital Specialty Finance, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MidCap Financial Investment$320.88M2.14$63.17M-$0.36N/A
Bain Capital Specialty Finance$78.39M8.49$98.76M$0.9910.37

In the previous week, Bain Capital Specialty Finance had 5 more articles in the media than MidCap Financial Investment. MarketBeat recorded 8 mentions for Bain Capital Specialty Finance and 3 mentions for MidCap Financial Investment. Bain Capital Specialty Finance's average media sentiment score of 0.75 beat MidCap Financial Investment's score of 0.08 indicating that Bain Capital Specialty Finance is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MidCap Financial Investment
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Bain Capital Specialty Finance
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Bain Capital Specialty Finance has a net margin of 24.22% compared to MidCap Financial Investment's net margin of -9.85%. MidCap Financial Investment's return on equity of 11.17% beat Bain Capital Specialty Finance's return on equity.

Company Net Margins Return on Equity Return on Assets
MidCap Financial Investment-9.85% 11.17% 4.41%
Bain Capital Specialty Finance 24.22%10.40%4.33%

MidCap Financial Investment currently has a consensus target price of $10.71, indicating a potential upside of 28.40%. Bain Capital Specialty Finance has a consensus target price of $12.60, indicating a potential upside of 22.75%. Given MidCap Financial Investment's higher possible upside, equities analysts clearly believe MidCap Financial Investment is more favorable than Bain Capital Specialty Finance.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MidCap Financial Investment
1 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Bain Capital Specialty Finance
0 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

28.5% of MidCap Financial Investment shares are owned by institutional investors. 0.9% of MidCap Financial Investment shares are owned by company insiders. Comparatively, 0.6% of Bain Capital Specialty Finance shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

MidCap Financial Investment pays an annual dividend of $1.24 per share and has a dividend yield of 14.9%. Bain Capital Specialty Finance pays an annual dividend of $1.68 per share and has a dividend yield of 16.4%. MidCap Financial Investment pays out -344.4% of its earnings in the form of a dividend. Bain Capital Specialty Finance pays out 169.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Bain Capital Specialty Finance has increased its dividend for 4 consecutive years. Bain Capital Specialty Finance is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

MidCap Financial Investment has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market. Comparatively, Bain Capital Specialty Finance has a beta of 0.6, suggesting that its stock price is 40% less volatile than the broader market.

Summary

MidCap Financial Investment and Bain Capital Specialty Finance tied by winning 9 of the 18 factors compared between the two stocks.

How does Bain Capital Specialty Finance compare to New Mountain Finance?

Bain Capital Specialty Finance (NYSE:BCSF) and New Mountain Finance (NASDAQ:NMFC) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings.

32.1% of New Mountain Finance shares are held by institutional investors. 0.6% of Bain Capital Specialty Finance shares are held by insiders. Comparatively, 14.9% of New Mountain Finance shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Bain Capital Specialty Finance pays an annual dividend of $1.68 per share and has a dividend yield of 16.4%. New Mountain Finance pays an annual dividend of $1.00 per share and has a dividend yield of 14.8%. Bain Capital Specialty Finance pays out 169.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. New Mountain Finance pays out -212.8% of its earnings in the form of a dividend. Bain Capital Specialty Finance has increased its dividend for 4 consecutive years. Bain Capital Specialty Finance is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Bain Capital Specialty Finance has a beta of 0.6, suggesting that its share price is 40% less volatile than the broader market. Comparatively, New Mountain Finance has a beta of 0.6, suggesting that its share price is 40% less volatile than the broader market.

Bain Capital Specialty Finance has higher earnings, but lower revenue than New Mountain Finance. New Mountain Finance is trading at a lower price-to-earnings ratio than Bain Capital Specialty Finance, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bain Capital Specialty Finance$78.39M8.49$98.76M$0.9910.37
New Mountain Finance$327.08M1.95$16.49M-$0.47N/A

In the previous week, Bain Capital Specialty Finance had 4 more articles in the media than New Mountain Finance. MarketBeat recorded 8 mentions for Bain Capital Specialty Finance and 4 mentions for New Mountain Finance. Bain Capital Specialty Finance's average media sentiment score of 0.75 beat New Mountain Finance's score of -0.08 indicating that Bain Capital Specialty Finance is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bain Capital Specialty Finance
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
New Mountain Finance
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral

Bain Capital Specialty Finance has a net margin of 24.22% compared to New Mountain Finance's net margin of -16.78%. New Mountain Finance's return on equity of 10.94% beat Bain Capital Specialty Finance's return on equity.

Company Net Margins Return on Equity Return on Assets
Bain Capital Specialty Finance24.22% 10.40% 4.33%
New Mountain Finance -16.78%10.94%4.58%

Bain Capital Specialty Finance presently has a consensus target price of $12.60, suggesting a potential upside of 22.75%. New Mountain Finance has a consensus target price of $7.67, suggesting a potential upside of 13.75%. Given Bain Capital Specialty Finance's stronger consensus rating and higher possible upside, research analysts plainly believe Bain Capital Specialty Finance is more favorable than New Mountain Finance.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bain Capital Specialty Finance
0 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
New Mountain Finance
1 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.80

Summary

Bain Capital Specialty Finance beats New Mountain Finance on 11 of the 17 factors compared between the two stocks.

Get Bain Capital Specialty Finance News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCSF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BCSF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BCSF vs. The Competition

MetricBain Capital Specialty FinanceCapital Markets IndustryFinance SectorNYSE Exchange
Market Cap$665.56M$5.11B$13.67B$23.20B
Dividend Yield15.80%7.61%6.08%3.69%
P/E Ratio10.3729.9124.6628.14
Price / Sales8.491,128.71478.9222.62
Price / Cash5.4747.4841.6434.60
Price / Book0.603.442.704.69
Net Income$98.76M$415.07M$1.32B$1.07B
7 Day Performance-3.34%-1.20%-0.53%-0.83%
1 Month Performance-7.23%-2.47%-2.58%-2.62%
1 Year Performance-26.28%8.54%10.79%6.88%

Bain Capital Specialty Finance Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BCSF
Bain Capital Specialty Finance
4.2425 of 5 stars
$10.27
-3.4%
$12.60
+22.7%
-26.3%$665.56M$78.39M10.371,000
ARCC
Ares Capital
3.2866 of 5 stars
$18.56
-0.4%
$20.39
+9.9%
-4.0%$13.33B$3.05B13.754,250
CCAP
Crescent Capital BDC
3.4268 of 5 stars
$9.14
flat
$12.63
+38.1%
-35.8%$336.81M$167.29MN/A250
CGBD
Carlyle Secured Lending
2.7635 of 5 stars
$10.48
-0.5%
$11.33
+8.1%
-15.8%$721.13M$255.57M20.552,500
MFIC
MidCap Financial Investment
3.1112 of 5 stars
$8.42
-0.2%
$10.71
+27.2%
-28.6%$693.58M-$11.90MN/AN/A

Related Companies and Tools


This page (NYSE:BCSF) was last updated on 10/18/2026 by MarketBeat.com Staff.
From Our Partners